Information accompanying the revision of the consumption tax rate
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India
Information on Service Brand Name Change
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center
Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth
Ajinomoto and XL-protein forge Strategic Alliance to develop PASylated therapeutics applying the Corynex® platform
Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing
Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines
Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry
Ajinomoto Althea, Inc. Announces Additions to Management Team as it transforms into a global CDMO
The Government of Flanders recently agreed to participate in Ajinomoto OmniChem’s investments into new and innovative technologies.